Theravance Biopharma Ownership & Insider Activity

Theravance Biopharma Inc

TBPHNASDAQ

$17.03

가까이에: Sep 25, 5:00 PM EST

$17.04

0.0140.08%

시간외: Sep 23, 5:58 PM EST

인수합병: Theravance Biopharma (TBPH) was acquired by Zymeworks (ZYME) on Wednesday, September 23, 2026 for $929M paid in cash

Theravance Biopharma (TBPH) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 14.3% of shares outstanding. Institutional investors hold 28.1%. Over the past 90 days, insiders made 3 sales worth $6.1M.

Shares Outstanding

51.919M

Shares Float

32.531M

Insider Shares Owned

7.413M

Insider % Owned

14.3%

Institutional Shares Held

14.595M

Institutional % Held

28.1%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$6.1M total

Net Activity

Net Selling

Net Value (90d)

-$6.1M

Date	Insider	Title	Type	Shares	Price	Value
Sep 15, 2026	Rhonda Farnum	SVP, COMM & MEDICAL AFFAIRS	SELL	13.314K	$17.03	$227K
Jul 6, 2026	Eli Samaha	10% OWNER	SELL	6.964K	$17.14	$119K
Jun 29, 2026	Eli Samaha	10% OWNER	SELL	336.697K	$17.20	$5.8M
Jun 15, 2026	Rhonda Farnum	SVP, COMM & MEDICAL AFFAIRS	SELL	13.314K	$16.39	$218K

Date	Member	Party	Chamber	Action	Amount
Mar 24, 2025	George Whitesides	D	House	Sale	$15,001 - $50,000